Impact of Hypoalbuminemia on Clinical Outcomes in Patients Receiving Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia
Limited research is available describing the relationship between serum albumin levels and clinical outcomes. Our study suggests patients with hypoalbuminemia treated with cefazolin for MSSA bacteremia have significantly longer time to culture clearance, increased mortality, and longer length of stay.
Authors
- Kevin Epps (ORCID: https://orcid.org/0000-0003-2780-233X)
- Dan Ilges (ORCID: https://orcid.org/0000-0003-0778-3901)
- John C. Robinson (ORCID: https://orcid.org/0000-0002-3061-2492)
- Kaylee Whitenack
- Alyssa McGary
Institutions
- WinnMed (US)
- Mayo Clinic Hospital (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2025-02-19
- DOI
- https://doi.org/10.1177/10600280251313874
- Citations
- 5
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 6.98
Funders
- Mayo Clinic